Comparison

Pomalidomide-PEG4-C2-NH2 (hydrochloride) European Partner

Item no. HY-112599B-50mg
Manufacturer MedChem Express
CASRN 2357105-92-9
Amount 50 mg
Quantity options 100 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Purity 97.01
Citations [1]Jian Jin, et al. Compositions and methods for treating ezh2-mediated cancer. WO2018081530A1.
Smiles O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3NCCOCCOCCOCCOCCN)=O.Cl
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
E3 Ligase Ligand-Linker Conjugates
Shipping Temperature
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Molecular Weight
528.98
Product Description
Pomalidomide-PEG4-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 4-unit PEG linker used in the synthesis of PROTACs..
Manufacturer - Research Area
Cancer
Solubility
DMSO: 220 mg/mL (ultrasonic)|H2O: 100 mg/mL (ultrasonic)
Manufacturer - Pathway
PROTAC
Isoform
Cereblon
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close